Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study
AbstractBackground: This randomized, double-blind, Phase IIIb study evaluated the 24-hour bronchodilatory efficacy of aclidinium bromide versus placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). Methods: Patients received aclidinium 400 μg twice...
Main Authors: | Jutta Beier, Anne-Marie Kirsten, Robert Mróz, Rosa Segarra, Ferran Chuecos, Cynthia Caracta, Esther Garcia Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2013-08-01
|
Series: | COPD |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.3109/15412555.2013.814626 |
Similar Items
-
Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019
by: Machado-Duque ME, et al.
Published: (2023-07-01) -
Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
by: Ji-Su Shim, MD, PhD, et al.
Published: (2022-12-01) -
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies
by: Victor Balaguer, et al.
Published: (2020-09-01) -
Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01) -
Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways
by: Paulina Hempel, et al.
Published: (2023-10-01)